| Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose-ethidium bromide electrophoresis PA Sharp, B Sugden, J Sambrook Biochemistry 12 (16), 3055-3063, 1973 | 1947 | 1973 |
| Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells JL Yates, N Warren, B Sugden Nature 313 (6005), 812-815, 1985 | 1712 | 1985 |
| A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. J Yates, N Warren, D Reisman, B Sugden Proceedings of the National Academy of Sciences 81 (12), 3806-3810, 1984 | 935 | 1984 |
| Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes W Hammerschmidt, B Sugden Nature 340 (6232), 393-397, 1989 | 745 | 1989 |
| A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus B Sugden, K Marsh, J Yates Molecular and cellular biology, 1985 | 597 | 1985 |
| A Putative Origin of Replication of Plasmids Derived from Epstein-Barr Virus Is Composed of Two cis-Acting Components D Reisman, J Yates, B Sugden Molecular and cellular biology 5 (8), 1822-1832, 1985 | 594 | 1985 |
| MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins S Sengupta, JA Den Boon, IH Chen, MA Newton, SA Stanhope, YJ Cheng, ... Proceedings of the National Academy of Sciences 105 (15), 5874-5878, 2008 | 547 | 2008 |
| Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus W Hammerschmidt, B Sugden Cell 55 (3), 427-433, 1988 | 535 | 1988 |
| trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 D Reisman, B Sugden Molecular and cellular biology 6 (11), 3838-3846, 1986 | 462 | 1986 |
| Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. VR Baichwal, B Sugden Oncogene 2 (5), 461-467, 1988 | 377 | 1988 |
| Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus T Mitchell, B Sugden Journal of virology 69 (5), 2968-2976, 1995 | 355 | 1995 |
| A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent … B Sugden, N Warren Journal of virology 63 (6), 2644-2649, 1989 | 352 | 1989 |
| Epstein-Barr virus provides a survival factor to Burkitt's lymphomas G Kennedy, J Komano, B Sugden Proceedings of the National Academy of Sciences 100 (24), 14269-14274, 2003 | 347 | 2003 |
| EBNA‐1: a protein pivotal to latent infection by Epstein–Barr virus ER Leight, B Sugden Reviews in medical virology 10 (2), 83-100, 2000 | 278 | 2000 |
| An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene TA Gahn, B Sugden Journal of virology 69 (4), 2633-2636, 1995 | 270 | 1995 |
| Clonal transformation of adult human leukocytes by Epstein-Barr virus B Sugden, W Mark Journal of virology 23 (3), 503-508, 1977 | 268 | 1977 |
| Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma S Sengupta, JA Den Boon, IH Chen, MA Newton, DB Dahl, M Chen, ... Cancer research 66 (16), 7999-8006, 2006 | 260 | 2006 |
| Agarose slab-gel electrophoresis equipment B Sugden, B DeTroy, RJ Roberts, J Sambrook Analytical biochemistry 68 (1), 36-46, 1975 | 227 | 1975 |
| The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells A Nanbo, A Sugden, B Sugden The EMBO journal 26 (19), 4252-4262, 2007 | 224 | 2007 |
| Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3 M Sandberg, W Hammerschmidt, B Sugden Journal of Virology 71 (6), 4649-4656, 1997 | 220 | 1997 |
